The Lapsus$ extortion group has claimed the theft of 3GB of data from AstraZeneca, including internal code repositories and ...
The group, known as LAPSUS$, maintain that they have stolen around 3GB of compressed AZ data, but somewhat unusually are ...
AstraZeneca plans a $15B China investment amid cardio-metabolic and oncology growth. Read the latest analysis on AZN stock ...
Zacks Investment Research on MSN
AstraZeneca (AZN) dips more than broader market: What you should know
Astrazeneca (AZN) closed at $183.60 in the latest trading session, marking a -2.82% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 1.51%. Meanwhile, the Dow ...
A major cyberattack has targeted pharmaceutical giant AstraZeneca. Hackers claim they stole internal company data and later offered it for sale on the dark web.
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 investor letter. It is a diversified fund that focuses on long-term capital appreciation by ...
AstraZeneca's shares jumped after Pfizer's announcement of a major deal with the Trump administration. Pfizer's good news could benefit AstraZeneca, too. Pfizer CEO Albert Bourla appeared with ...
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR T cell therapies in China.
The planned Shanghai facility extends a yearslong push into the field and will support CAR-T therapies AstraZeneca is making for autoimmune disease and cancer.
AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration - though much of what it is ...
AstraZeneca AZN is scheduled to report fourth-quarter and full-year 2025 results on Feb. 10, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 4.39% ...
AstraZeneca's shares jumped after Pfizer's announcement of a major deal with the Trump administration. Pfizer's good news could benefit AstraZeneca, too. 10 stocks we like better than AstraZeneca Plc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results